Revance Therapeutics Inc (RVNC)

[DewDiligence]

RVNC fully-diluted shares @9/30/22=101.2M:

• 82.3M basic shares on the 9/30/22 balance sheet (https://www.sec.gov/ix?doc=/Archives/edgar/data/0001479290/000147929022000102/rvnc-20220930.htm#i0dce85bfa8324dd5b3e1f591bbdb2e39_16 );

• 5.0M options and 5.0M shares of unvested restricted stock and RSUs (ibid p.25);

• 8.9M shares deriving from the convertible debt issued in Feb 2020.

Note: No shares have been sold under the 2022 ATM facility.